|
Delayed
Australian S.E.
21:25:01 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 8.160 AUD | -1.09% |
|
+1.75% | -34.51% |
| Market Cap | 416M 288M 256M 239M 218M 410M 27.73B 2.89B 1.12B 14.12B 1.08B 1.06B 45.36B | P/E 2027 * |
11.9x | P/E 2028 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 133M 91.97M 81.69M 76.4M 69.62M 131M 8.86B 924M 358M 4.51B 345M 338M 14.49B | EV / Sales 2027 * |
1.4x | EV / Sales 2028 * | 0.99x |
| Free-Float |
83.79% | Yield 2027 * |
0.66% | Yield 2028 * | 0.74% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CUV | Delayed | |
Tradegate
| UR9 | Real-time | |
|
OTC Markets
| CLVL.F | Delayed | |
|
Boerse Muenchen
| UR9 | Real-time | |
|
Berne S.E.
| UR9 | End-of-day quote | |
|
Deutsche Boerse AG
| UR9 | Delayed | |
|
Börse Stuttgart
| UR9 | Delayed |
Last Transcript: Clinuvel Pharmaceuticals Limited
| 1 day | -0.61% | ||
| 1 week | +2.24% | ||
| Current month | -4.65% | ||
| 1 month | -1.91% | ||
| 3 months | -20.08% | ||
| 6 months | -9.09% | ||
| Current year | -34.19% |
| 1 week | 7.95 |  | 8.6 |
| 1 month | 7.93 | | 8.64 |
| Current year | 7.93 | | 13.48 |
| 1 year | 7.93 | | 13.48 |
| 3 years | 7.93 | | 18.2 |
| 5 years | 7.93 | | 42.86 |
| 10 years | 5.91 | | 45.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 63 | 2005-10-31 |
Peter Vaughan
DFI | Director of Finance/CFO | 42 | 2024-06-29 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karen Agersborg
BRD | Director/Board Member | - | 2018-01-28 |
Susan Smith
BRD | Director/Board Member | - | 2019-09-22 |
| Chairman | - | 2023-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/3/24 | Buy | Director | 8,333 | 0.0166% | ||
| 11/27/23 | Exercice | Chief Executive Officer | 301,125 | 0.6094% | ||
| 11/27/23 | Expiration | Chief Executive Officer | 1,513,750 | 3.0636% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | +2.24% | -32.29% | -44.37% | 302M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,031B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 638B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 462B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -2.97% | -3.25% | +8.38% | 253B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 228B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 185B | |
| Average | -1.33% | -1.03% | +23.01% | +47.17% | 376.42B | |
| Weighted average by Cap. | -1.25% | -1.89% | +31.78% | +69.17% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 94.86M 65.67M 58.33M 54.55M 49.71M 93.58M 6.32B 660M 255M 3.22B 247M 241M 10.34B | 101M 70.06M 62.23M 58.2M 53.03M 99.84M 6.75B 704M 273M 3.44B 263M 257M 11.03B |
| Net income | 35.1M 24.3M 21.58M 20.18M 18.39M 34.62M 2.34B 244M 94.51M 1.19B 91.22M 89.25M 3.83B | 36.66M 25.38M 22.54M 21.08M 19.21M 36.16M 2.44B 255M 98.72M 1.24B 95.28M 93.21M 4B |
| Net Debt | -283M -196M -174M -163M -148M -279M -18.87B -1.97B -762M -9.61B -736M -720M -30.87B | -316M -219M -194M -182M -166M -312M -21.05B -2.2B -851M -10.72B -821M -803M -34.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | A$8.160 | -1.09% | 13,975 |
| 26-10-01 | A$8.250 | -4.07% | 123,328 |
| 26-09-30 | A$8.600 | +2.63% | 136,134 |
| 26-09-29 | A$8.380 | +2.57% | 135,007 |
| 26-09-28 | A$8.170 | +1.87% | 91,901 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CUV Stock
Select your edition
All financial news and data tailored to specific country editions
